BELLICUM PHARMACEUTICALS, INC Business Finance Contracts & Agreements
30 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Loan Agreements (7)
- Note Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (8)
- Form of pre-funded warrant issued in December 2021 private placement (Filed With SEC on December 6, 2021)
- Form of accompanying common warrant issued in December 2021 private placement (Filed With SEC on December 6, 2021)
- Securities Purchase Agreement, dated December 4, 2021, by and among the Company and the purchasers named therein (Filed With SEC on December 6, 2021)
- Underwriting Agreement, dated October 29, 2020, by and between Bellicum Pharmaceuticals and H.C. Wainwright & Co (Filed With SEC on November 2, 2020)
- Form of pre-funded warrant (Filed With SEC on November 2, 2020)
- Form of warrant to purchase common stock (Filed With SEC on November 2, 2020)
- Second Amendment to Loan and Security Agreement, dated March 31, 2020, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 7, 2020)
- First Amendment to Loan and Security Agreement, dated December 24, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 12, 2020)
- First Amendment to Asset Purchase Agreement, dated February 21, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)
- Asset Purchase Agreement, dated January 17, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)
- Underwriting Agreement, dated August 16, 2019, by and among the Company, Jefferies LLC and Wells Fargo Securities, LLC, as representative of the several underwriters identified... (Filed With SEC on August 19, 2019)
- Form of Warrant issued in public offering (Filed With SEC on August 19, 2019)
- Form of Warrant issued in private placement (Filed With SEC on August 19, 2019)
- Securities Purchase Agreement, dated August 16, 2019, by and among the Company and the institutional investors named therein (Filed With SEC on August 19, 2019)
- Underwriting Agreement, dated April 17, 2018, among Bellicum Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Jefferies LLC, as representatives for the several underwriters (Filed With SEC on April 18, 2018)
- Loan and Security Agreement by and between the Registrant and Oxford Finance LLC dated as of December 21, 2017 (Filed With SEC on March 13, 2018)
- 5,000,000 Shares Bellicum Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 24, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on May 9, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 14, 2016)
- [Number of Shares] Bellicum Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2014)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 18, 2014)
- INVESTOR RIGHTS AGREEMENT BETWEEN BELLICUMPHARMACEUTICALS, INC. AND ARIAD GENE THERAPEUTICS, INC. AND ARIADPHARMACEUTICALS, INC. (Filed With SEC on November 18, 2014)
- BELLICUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE SERIES C PREFERRED STOCK (Filed With SEC on November 18, 2014)
- COMMON STOCK PURCHASE WARRANT OF BELLICUMPHARMACEUTICALS, INC. (Filed With SEC on November 18, 2014)
- BELLICUMPHARMACEUTICALS, INC. 2006 STOCK OPTION PLAN (Filed With SEC on November 18, 2014)
- BELLICUM PHARMACEUTICALS, INC. 2011 STOCK OPTION PLAN (Filed With SEC on November 18, 2014)
- PROMISSORY NOTE (Filed With SEC on November 18, 2014)
- BELLICUM PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 18, 2014)
